Drugs / Autologous tumor cell + CpG vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00780988 | — | colorectal cancer | Stanford University | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous tumor cell + CpG vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00780988 ↗ |
| Modality | Vaccine | “to create a vaccine” NCT00780988 ↗ |
| Route | Subcutaneous | “Patients will receive subcutaneous vaccination at weeks 1 and 2 after resection” NCT00780988 ↗ |